BS

Bhupendra Singh Kataria

Active Director Director DIN 11684702
DIN 11684702 First appointment Apr 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhupendra Singh Kataria

Data last updated:

Bhupendra Singh Kataria is a Director at Deccan Health Care Limited (since 2026). The company operates in Pharma.

DIN 11684702
Primary Designation Director
Industry Pharma
First Appointment 25 Apr 2026
Oldest Company Age 30 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deccan Health Care Limited L72200TG1996PLC024351
Director25 Apr 20261996Active

Directorship timeline

Open interactive timeline →
Deccan Health Care Limited
Premium access

Shareholding and investment profile for Bhupendra Singh Kataria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhupendra Singh Kataria

Bhupendra Singh Kataria currently holds 1 directorship: Deccan Health Care Limited (Director, since 25 Apr 2026).

Bhupendra Singh Kataria was first appointed on 25 Apr 2026 as Director at Deccan Health Care Limited.

The current boards of Bhupendra Singh Kataria's companies include Manju Singh (Deccan Health Care Limited), Meenakshi Gupta (Deccan Health Care Limited), Minto Purshotam Gupta (Deccan Health Care Limited), Mohak Gupta (Deccan Health Care Limited), Pratiksha Bisht (Deccan Health Care Limited), Ravi Ramprasad (Deccan Health Care Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available